CD45 correlates with adverse risk stratification, decreased treatment response and unfavorable survival profiles in elderly acute myeloid leukemia patients.

CONCLUSIONS: CD45 correlates with adverse risk stratification, decreased treatment response and unfavorable survival profiles in elderly AML patients. PMID: 30347598 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30347598?dopt=Abstract

Source: Cancer Biomarkers - October 24, 2018 Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research